[HTML][HTML] Molecular magnetic resonance imaging in cancer
The ability to identify key biomolecules and molecular changes associated with cancer
malignancy and the capacity to monitor the therapeutic outcome against these targets is …
malignancy and the capacity to monitor the therapeutic outcome against these targets is …
Magnetic resonance imaging of cancer metabolism with hyperpolarized 13C-labeled cell metabolites
RL Hesketh, KM Brindle - Current opinion in chemical biology, 2018 - Elsevier
Highlights•Hyperpolarization of 13 C substrates by dissolution dynamic nuclear polarization
can increase NMR signal by> 10 4.•Many hyperpolarized substrates have been developed …
can increase NMR signal by> 10 4.•Many hyperpolarized substrates have been developed …
Optical metabolic imaging identifies glycolytic levels, subtypes, and early-treatment response in breast cancer
Abnormal cellular metabolism is a hallmark of cancer, yet there is an absence of quantitative
methods to dynamically image this powerful cellular function. Optical metabolic imaging …
methods to dynamically image this powerful cellular function. Optical metabolic imaging …
Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment
D Roblyer, S Ueda, A Cerussi… - Proceedings of the …, 2011 - National Acad Sciences
Approximately 8–20% of breast cancer patients receiving neoadjuvant chemotherapy fail to
achieve a measurable response and endure toxic side effects without benefit. Most clinical …
achieve a measurable response and endure toxic side effects without benefit. Most clinical …
Breast cancer recurrence diagnosis suspected on tumor marker rising: Value of whole‐body 18FDG‐PET/CT imaging and impact on patient management
BACKGROUND: Breast cancer recurrence is often suspected on tumor marker rising in
asymptomatic patients. The value of fluorine‐18 fluorodeoxyglucose (18FDG)–positron …
asymptomatic patients. The value of fluorine‐18 fluorodeoxyglucose (18FDG)–positron …
18F-Fluoroestradiol
L Sundararajan, HM Linden, JM Link, KA Krohn… - Seminars in nuclear …, 2007 - Elsevier
Estrogen receptor (ER) expression is an important determinant of breast cancer behavior
and is critical for response to endocrine therapies such as tamoxifen and aromatase …
and is critical for response to endocrine therapies such as tamoxifen and aromatase …
Current trends in preclinical PET system design
CS Levin, H Zaidi - PET clinics, 2007 - Elsevier
PET is used in laboratory small-animal research to visualize and track certain molecular
processes associated with diseases such as cancer, heart disease, and neurologic …
processes associated with diseases such as cancer, heart disease, and neurologic …
Monitoring predominantly cytostatic treatment response with 18F-FDG PET
KB Contractor, EO Aboagye - Journal of Nuclear Medicine, 2009 - Soc Nuclear Med
18 F-FDG PET and, more recently, PET/CT have been established as response biomarkers
for monitoring cytotoxic or cytoreductive cancer therapies. With the advent of targeted cancer …
for monitoring cytotoxic or cytoreductive cancer therapies. With the advent of targeted cancer …
[HTML][HTML] A method for model-free partial volume correction in oncological PET
Background As is well known, limited spatial resolution leads to partial volume effects (PVE)
and consequently to limited signal recovery. Determination of the mean activity …
and consequently to limited signal recovery. Determination of the mean activity …
GlucoCEST MRI for the Evaluation Response to Chemotherapeutic and Metabolic Treatments in a Murine Triple-Negative Breast Cancer: A Comparison with[18F]F …
Purpose Triple-negative breast cancer (TNBC) patients have usually poor outcome after
chemotherapy and early prediction of therapeutic response would be helpful.[18F] F-FDG …
chemotherapy and early prediction of therapeutic response would be helpful.[18F] F-FDG …